Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 1 (1)

Trial Status

Recruiting1
Active Not Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06960915Not ApplicableActive Not Recruiting

Efficacy of Virtual Reality Reminiscence Therapy in Nursing Home Residents With Alzheimer's Disease or Related Diseases

NCT07179848Phase 1Recruiting

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Showing all 2 trials

Research Network

Activity Timeline